p21-activated kinase 1: PAK'ed with potential
The p21-activated kinases (PAKs) are central players in growth factor signaling networks and morphogenetic processes that control proliferation, cell polarity, invasion and actin cytoskeleton organization. This raises the possibility that interfering with PAK activity may produce significant anti-tu...
Main Authors: | , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Impact Journals LLC
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248206/ |
id |
pubmed-3248206 |
---|---|
recordtype |
oai_dc |
spelling |
pubmed-32482062012-01-18 p21-activated kinase 1: PAK'ed with potential Ong, Christy C. Jubb, Adrian M. Zhou, Wei Haverty, Peter M. Harris, Adrian L. Belvin, Marcia Friedman, Lori S. Koeppen, Hartmut Hoeflich, Klaus P. Research Perspectives The p21-activated kinases (PAKs) are central players in growth factor signaling networks and morphogenetic processes that control proliferation, cell polarity, invasion and actin cytoskeleton organization. This raises the possibility that interfering with PAK activity may produce significant anti-tumor activity. In this perspective, we summarize recent data concerning the contribution of the PAK family member, PAK1, in growth factor signaling and tumorigenesis. We further discuss mechanisms by which inhibition of PAK1 can arrest tumor growth and promote cell apoptosis, and the types of cancers in which PAK1 inhibition may hold promise. Impact Journals LLC 2011-06-07 /pmc/articles/PMC3248206/ /pubmed/21653999 Text en Copyright: © 2011 Ong et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited |
repository_type |
Open Access Journal |
institution_category |
Foreign Institution |
institution |
US National Center for Biotechnology Information |
building |
NCBI PubMed |
collection |
Online Access |
language |
English |
format |
Online |
author |
Ong, Christy C. Jubb, Adrian M. Zhou, Wei Haverty, Peter M. Harris, Adrian L. Belvin, Marcia Friedman, Lori S. Koeppen, Hartmut Hoeflich, Klaus P. |
spellingShingle |
Ong, Christy C. Jubb, Adrian M. Zhou, Wei Haverty, Peter M. Harris, Adrian L. Belvin, Marcia Friedman, Lori S. Koeppen, Hartmut Hoeflich, Klaus P. p21-activated kinase 1: PAK'ed with potential |
author_facet |
Ong, Christy C. Jubb, Adrian M. Zhou, Wei Haverty, Peter M. Harris, Adrian L. Belvin, Marcia Friedman, Lori S. Koeppen, Hartmut Hoeflich, Klaus P. |
author_sort |
Ong, Christy C. |
title |
p21-activated kinase 1: PAK'ed with potential |
title_short |
p21-activated kinase 1: PAK'ed with potential |
title_full |
p21-activated kinase 1: PAK'ed with potential |
title_fullStr |
p21-activated kinase 1: PAK'ed with potential |
title_full_unstemmed |
p21-activated kinase 1: PAK'ed with potential |
title_sort |
p21-activated kinase 1: pak'ed with potential |
description |
The p21-activated kinases (PAKs) are central players in growth factor signaling networks and morphogenetic processes that control proliferation, cell polarity, invasion and actin cytoskeleton organization. This raises the possibility that interfering with PAK activity may produce significant anti-tumor activity. In this perspective, we summarize recent data concerning the contribution of the PAK family member, PAK1, in growth factor signaling and tumorigenesis. We further discuss mechanisms by which inhibition of PAK1 can arrest tumor growth and promote cell apoptosis, and the types of cancers in which PAK1 inhibition may hold promise. |
publisher |
Impact Journals LLC |
publishDate |
2011 |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248206/ |
_version_ |
1611497305923387392 |